Teratogenicity of zonisamide and other little-used antiseizure medications
- 2 March 2024
- journal article
- research article
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 117, 198-201
Abstract
No abstract availableKeywords
Funding Information
- Royal Melbourne Hospital
- National Health and Medical Research Council
- Royal Melbourne Hospital Neuroscience Foundation
- Epilepsy Society of Australia
This publication has 10 references indexed in Scilit:
- Changes over 24 years in a pregnancy register – Teratogenicity and epileptic seizure controlEpilepsy & Behavior, 2023
- Specific fetal malformations following intrauterine exposure to antiseizure medicationEpilepsy & Behavior, 2023
- Teratogenic effects of zonisamideSeizure: European Journal of Epilepsy, 2021
- Zonisamide safety in pregnancy: Data from the UK and Ireland epilepsy and pregnancy registerSeizure: European Journal of Epilepsy, 2021
- Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomesBMC Medicine, 2017
- Developmental effects of antiepileptic drugs and the need for improved regulationsNeurology, 2016
- The Australian Pregnancy Register of Anti-epileptic Drugs : 10 years of progressJournal of Clinical Neuroscience, 2010
- The Australian Register of Antiepileptic Drugs in Pregnancy: The first 1002 pregnanciesAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2007
- Statistics on Deliveries of Mothers with Epilepsy at Yokohama City University HospitalEpilepsia, 2004
- Preliminary Report on Teratogenic Effects of Zonisamide in the Offspring of Treated Women with EpilepsyEpilepsia, 1996